| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $789.8M | +0.4% |
| Cost of Revenue | $271.4M | -7.9% |
| Gross Profit | $518.4M | +5.4% |
| R&D Expense | $101.5M | -19.1% |
| SG&A Expense | $93.0M | -3.3% |
| Operating Income | -$4.2M | +95.3% |
| Pre-tax Income | $8.3M | +110.3% |
| Income Tax | $4.5M | +4.1% |
| Net Income | $3.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $231.5M | +21.5% |
| Short-term Investments | $127.3M | -22.3% |
| Accounts Receivable | $95.9M | +8.7% |
| Current Assets | $524.2M | +3.5% |
| Total Assets | $617.7M | +2.0% |
| Current Liabilities | $400.1M | +0.7% |
| Total Liabilities | $407.2M | -0.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $87.7M | +65.3% |
| Capital Expenditures | $5.8M | +152.3% |
| Investing Cash Flow | $20.6M | +1815.4% |
| Financing Cash Flow | -$68.5M | +60.1% |
| Free Cash Flow | $81.9M | +61.3% |
| +104.5% |
| EPS (Basic) | $0.03 | +105.4% |
| EPS (Diluted) | $0.03 | +105.4% |
| Stockholders' Equity |
| $210.5M |
| +6.6% |